NO995683D0 - Vitamin D analoger og deres neuronale effekter - Google Patents

Vitamin D analoger og deres neuronale effekter

Info

Publication number
NO995683D0
NO995683D0 NO995683A NO995683A NO995683D0 NO 995683 D0 NO995683 D0 NO 995683D0 NO 995683 A NO995683 A NO 995683A NO 995683 A NO995683 A NO 995683A NO 995683 D0 NO995683 D0 NO 995683D0
Authority
NO
Norway
Prior art keywords
analogues
vitamin
neuronal effects
neuronal
effects
Prior art date
Application number
NO995683A
Other languages
English (en)
Other versions
NO995683L (no
Inventor
Susan Carswell
Fredrik Bjoerkling
Pawel Dobrzanski
Lise Binderup
Matthew S Miller
Original Assignee
Cephalon Inc
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc, Leo Pharm Prod Ltd filed Critical Cephalon Inc
Publication of NO995683D0 publication Critical patent/NO995683D0/no
Publication of NO995683L publication Critical patent/NO995683L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO995683A 1997-05-22 1999-11-19 Vitamin D analoger og deres neuronale effekter NO995683L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4739197P 1997-05-22 1997-05-22
PCT/US1998/010480 WO1998052574A1 (en) 1997-05-22 1998-05-21 Vitamin d analogues and their neuronal effects
US09/082,762 US6207656B1 (en) 1997-05-22 1998-05-21 Vitamin D analogues and their neuronal effects

Publications (2)

Publication Number Publication Date
NO995683D0 true NO995683D0 (no) 1999-11-19
NO995683L NO995683L (no) 2000-01-19

Family

ID=26724967

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995683A NO995683L (no) 1997-05-22 1999-11-19 Vitamin D analoger og deres neuronale effekter

Country Status (8)

Country Link
US (1) US6207656B1 (no)
EP (1) EP1011683A4 (no)
JP (1) JP2002513416A (no)
KR (1) KR20010012770A (no)
AU (1) AU728037B2 (no)
CA (1) CA2290772A1 (no)
NO (1) NO995683L (no)
WO (1) WO1998052574A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1206448E (pt) * 1999-08-04 2004-08-31 Leo Pharma As Novos analogos de vitamina d
US20030105027A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
US20030118536A1 (en) * 2001-11-06 2003-06-26 Rosenbloom Richard A. Topical compositions and methods for treatment of adverse effects of ionizing radiation
US7435725B2 (en) * 2001-11-06 2008-10-14 The Quigly Corporation Oral compositions and methods for prevention, reduction and treatment of radiation injury
WO2004026248A2 (en) * 2002-09-20 2004-04-01 Merck & Co., Inc. Octahydro-2-h-naphtho[1,2-f] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
AR041696A1 (es) * 2002-10-23 2005-05-26 Leo Pharm Prod Ltd Compuestos analogos de vitamina d, composiciones que comprenden dichos compuestos analogos y su uso
US20050192255A1 (en) * 2003-07-30 2005-09-01 Jin Tian Use of Vitamin Ds or Vitamin D analogs to treat cardiovascular disease
US20050209203A1 (en) * 2003-07-30 2005-09-22 Jin Tian Use of vitamin Ds or vitamin D analogs to treat cardiovascular disease
US20060171983A1 (en) * 2003-07-30 2006-08-03 Jin Tian Use of Vitamin D receptor activators or Vitamin D analogs to treat cardiovascular disease
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
US20080069814A1 (en) * 2005-01-05 2008-03-20 Novacea, Inc. Prevention of Thrombotic Disorders with Active Vitamin D Compounds or Mimics Thereof
MX2007013029A (es) * 2005-04-22 2008-01-11 Novacea Inc Tratamiento, prevencion y mejora de trastornos pulmonares asociados con la quimioterapia o radioterapia con compuestos activos de vitamina d o substancias mimeticas de los mismos.
CA2622761A1 (en) * 2005-09-16 2007-03-22 Coley Pharmaceutical Gmbh Modulation of immunostimulatory properties of short interfering ribonucleic acid (sirna) by nucleotide modification
KR20080072934A (ko) * 2005-11-25 2008-08-07 콜리 파마슈티칼 게엠베하 면역자극성 올리고리보뉴클레오티드
US8377913B2 (en) * 2007-11-20 2013-02-19 Abbvie Inc. Vitamin D receptor activators and methods of making
JP5932339B2 (ja) 2009-01-27 2016-06-08 バーグ エルエルシー 化学療法に付随する副作用を軽減するためのビタミンｄ３およびその類似体
US20110306579A1 (en) * 2009-01-30 2011-12-15 Emory University Methods of neuroprotection using neuroprotective steroids and a vitamin d
CN102482210B (zh) * 2009-04-17 2015-04-08 维达西姆公司 维生素d受体激动剂及其用途
MX366076B (es) 2009-08-14 2019-06-27 Berg Llc Vitamina d3 y analogos de la misma para tratar alopecia.
US20140296190A1 (en) * 2013-03-27 2014-10-02 Dsm Ip Assets B.V. Marketing the use of 25-hydroxyvitamin d3 to enhance cognition
CN112156097A (zh) 2013-05-29 2021-01-01 博格有限责任公司 使用维生素d预防或减轻化疗诱发的脱发

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0144358B1 (ko) 1988-04-21 1998-07-15 피. 라이달 크리스텐슨 비타민 d 동족체
US4897388A (en) * 1988-12-20 1990-01-30 Geriatric Research Institute, Inc. Method of treating Alzheimer's disease
US5093317A (en) 1989-06-05 1992-03-03 Cephalon, Inc. Treating disorders by application of insulin-like growth factor
GB9007236D0 (en) 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds
GB9206648D0 (en) 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
US5420112A (en) 1992-06-12 1995-05-30 Lewis; Michael E. Prevention and treatment of peripheral neuropathy
GB9314400D0 (en) 1993-07-12 1993-08-25 Leo Pharm Prod Ltd Produktionsaktieselskab) chemical compounds
IL110309A0 (en) 1993-07-15 1994-10-21 Univ Kentucky Res Found A method of protecting against neuron loss
GB9325415D0 (en) 1993-12-13 1994-02-16 Res Inst Medicine Chem Chemical compounds
US5731284A (en) * 1995-09-28 1998-03-24 Amgen Inc. Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product
US5716946A (en) * 1996-02-13 1998-02-10 Wisconsin Alumni Research Foundation Multiple sclerosis treatment

Also Published As

Publication number Publication date
KR20010012770A (ko) 2001-02-26
EP1011683A1 (en) 2000-06-28
AU7691798A (en) 1998-12-11
JP2002513416A (ja) 2002-05-08
WO1998052574A1 (en) 1998-11-26
AU728037B2 (en) 2001-01-04
EP1011683A4 (en) 2003-06-11
US6207656B1 (en) 2001-03-27
NO995683L (no) 2000-01-19
CA2290772A1 (en) 1998-11-26

Similar Documents

Publication Publication Date Title
NO995683D0 (no) Vitamin D analoger og deres neuronale effekter
ATE288410T1 (de) Vitamin d-analoga
NO20001323D0 (no) Dipeptid-apoptose inhibitorer og deres anvendelse
NO971811D0 (no) Bicykliske tetrahydropyrazolopyridiner og deres anvendelse som legemidler
NO993467D0 (no) Granuler som innbefatter klavulanat og en eller flere eksipienter
NO994510L (no) Substituerte isokinolin-derivater og deres anvendelse som antikonvulsanter
DK0946566T3 (da) Prodrugformer og camptothecinanaloger og deres anvendelse som lægemidler
DE19882595T1 (de) Schmuckstück
NO20010119L (no) Preparater omfattende GABA-analoger og kaffein
NO995513L (no) N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-
DK0906529T3 (da) Aktiveringsstift
DE59809171D1 (de) Verschraubungseinrichtung
NO984921D0 (no) Tienopyridinderivater og deres anvendelse
KR970062259U (ko) 연단기
FI961661A (fi) Liitin
NO971333D0 (no) Styre- og manövreringsstikke
DE69834398D1 (de) Anhänger
FI972010A0 (fi) Arrangemang i en borrningsanordning
KR960026534U (ko) 뺏지핀
BR9505341A (pt) Jogo
KR970062642U (ko) 소형묘비
DK0983294T3 (da) B-Ring-østratriendiol-sulfater
FI971706A0 (fi) Traenings- och toejningsanordning
FR2735973B1 (fr) Botte anti-equin et anti-escarre gonflable
BR7700428U (pt) Simulador de nado